ARTIDIS is a company that has developed a nanomechanical sensor capable of differentiating between benign and malignant tissue in less than three hours. The technology also allows clinicians to accurately determine the aggressiveness of a tumor based on the nanomechanical signature of cells. The company's nano-probe measures the physical properties of tissue, allowing for the discovery of nano-mec...